SCHEMBL17103

SCHEMBL17103

CC(O)(c1ccc(N2CCN(S(=O)(=O)C3=CC=CCC3=S)C[C@H]2CNS(=O)(=O)O)cc1)C(F)(F)F

nearest known ligand 0.46

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GCK P35557 14/20 0.46
GCKR Q14397 7/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17365 0.93 GCK (0.46) GCKGCKR
SCHEMBL12079570 0.92 GCK (0.45) GCKGCKR
SCHEMBL17096 0.92 GCK (0.45) GCKGCKR
SCHEMBL17048 0.92 GCK (0.45) GCKGCKR
SCHEMBL17729 0.92 GCK (0.47) GCKGCKR
SCHEMBL16930 0.91 GCK (0.44) GCKGCKR
SCHEMBL16592 0.91 GCK (0.44) GCKGCKR
SCHEMBL17016 0.91 GCK (0.44) GCKGCKR
SCHEMBL17188 0.90 GCK (0.46) GCKGCKR
SCHEMBL17400 0.90 GCK (0.46) GCKGCKR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2609081-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES Amgen Inc. (US) 2013-07-03 EP disclosed
WO-2012027261-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES AMGEN INC. (US) 2012-03-01 WO disclosed